ADC Therapeutics SA annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
ADC Therapeutics SA Revenue Growth & History (ADCT)
ADC Therapeutics SA reported $81.4M in revenue for fiscal 2025, an increase of 14.85% from the previous fiscal year.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $81.4M | $10.5M | +14.85% |
| 2024 | 2024-12-31 | $70.8M | $1.8M | +2.57% |
| 2023 | 2023-12-31 | $69.1M | −$140.8M | −67.10% |
| 2022 | 2022-12-31 | $209.9M | $176.0M | +518.89% |
| 2021 | 2021-12-31 | $33.9M | $33.9M | — |
| 2020 | 2020-12-31 | $0 | −$2.3M | −100.00% |
| 2019 | 2019-12-31 | $2.3M | $1.2M | +105.26% |
| 2018 | 2018-12-31 | $1.1M | — | — |
ADC Therapeutics SA quarterly revenue
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.6M | $549,000 | +3.04% |
| Q1 2026 | 2026-03-31 | $20.0M | $2.6M | +15.11% |
| Q4 2025 | 2025-12-31 | $30.1M | $12.2M | +67.85% |
| Q3 2025 | 2025-09-30 | $15.8M | −$2.3M | −12.58% |
| Q2 2025 | 2025-06-30 | $18.1M | $1.1M | +6.19% |
| Q1 2025 | 2025-03-31 | $17.4M | −$444,000 | −2.49% |
| Q4 2024 | 2024-12-31 | $17.9M | $1.7M | +10.13% |
| Q3 2024 | 2024-09-30 | $18.0M | $3.5M | +24.31% |
| Q2 2024 | 2024-06-30 | $17.0M | −$2.3M | −11.68% |
| Q1 2024 | 2024-03-31 | $17.8M | −$1.1M | −6.02% |
| Q4 2023 | 2023-12-31 | $16.3M | −$53.5M | −76.66% |
| Q3 2023 | 2023-09-30 | $14.5M | −$61.8M | −81.01% |
| Q2 2023 | 2023-06-30 | $19.3M | $2.0M | +11.52% |
| Q1 2023 | 2023-03-31 | $19.0M | −$27.5M | −59.16% |
| Q4 2022 | 2022-12-31 | $69.8M | $52.8M | +310.34% |
| Q3 2022 | 2022-09-30 | $76.3M | $63.2M | +480.52% |
| Q2 2022 | 2022-06-30 | $17.3M | $13.5M | +359.87% |
| Q1 2022 | 2022-03-31 | $46.5M | $46.5M | — |
| Q4 2021 | 2021-12-31 | $17.0M | — | — |
| Q3 2021 | 2021-09-30 | $13.1M | $13.1M | — |
| Q2 2021 | 2021-06-30 | $3.8M | $3.8M | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
ADC Therapeutics SA revenue growth trends
ADC Therapeutics SA's latest reported quarter, Q2 2026, generated $18.6M in revenue, an increase of 3.04% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review ADC Therapeutics SA source filings ↗